You are here

  • Home
  • Archive
  • Volume 70, Issue 4
  • Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Citation Tools

Article menu

This article has a correction. Please see:

Download PDFPDF

Clinical and epidemiological research
Extended report
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Song I, Hermann K, Haibel H, et al
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial
Annals of the Rheumatic Diseases 2011;70:590-596.